Freenome, an early cancer detection company developing blood-based screening tests, today is reporting the improved clinical performance of an updated version of its SimpleScreen™ CRC test. In data ...

Early-stage detection of colorectal cancer (CRC) could be achieved using a noninvasive multiomics liquid biopsy test, according to a recent study. CRC is the third most common cancer globally and is ...

A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...

A stiffer colon may be an early warning sign of rising colorectal cancer in younger adults. What researchers are discovering ...

Here are the top 5 most-read CRC articles in 2025. From cutting-edge AI detection tools to rising incidence in younger adults ...

Colorectal cancer (CRC) is the second most commonly diagnosed cancer in China and a leading cause of cancer-related mortality. Despite improvements in treatment, the survival rate remains lower than ...

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of ...

(RTTNews) - Mainz Biomed NV (MYNZ), a molecular genetics diagnostic company, on Tuesday announced the launch of the eAArly DETECT 2 feasibility study to evaluate its next-generation colorectal cancer ...

For uninsured patients who are at a high risk for colorectal cancer (CRC), performing free screening colonoscopies can identify cancer at an earlier stage and appears to be cost neutral from a ...

(RTTNews) - Mainz Biomed N.V. (MYNZ) on Friday announced plans to provide an interim readout of its ongoing eAArly DETECT 2 clinical study by the end of summer 2025. The study is evaluating the ...